(Q37728734)

22 August 2017

1 reference

title

Early clinical development of anti-tuberculosis drugs: science, statistics and sterilizing activity (English)

1 reference

22 August 2017

0 references

0 references

1

Geraint R Davies

1 reference

22 August 2017

language of work or name

1 reference

10 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

90

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

171-176

1 reference

Challenges in tuberculosis drug research and development

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Assessment of the Efficacy of New Anti-Tuberculosis Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

STREPTOMYCIN treatment of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Basic Mechanisms of Chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Surrogate endpoints in clinical trials: definition and operational criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

The validation of surrogate endpoints in meta-analyses of randomized experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

A perfect correlate does not a surrogate make

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Learning versus confirming in clinical drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Biomarkers for tuberculosis disease activity, cure, and relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Early bactericidal activity of antituberculosis agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

A multicentre study of the early bactericidal activity of anti-tuberculosis drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Sources of variation in studies of the early bactericidal activity of antituberculosis drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Use of nonlinear mixed-effects analysis for improved precision of early pharmacodynamic measures in tuberculosis treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.007

10.1016/J.TUBE.2010.03.007

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference